Morphological, biochemical and behavioural changes induced by neurotoxic and inflammatory insults to the nucleus basalis

International Journal of Developmental Neuroscience

Volumn 16, Issue 7-8, 1998, Pages 705-714

  Casamenti, Fiorella ^a   Prosperi, Costanza ^a   Scali, Carla ^a   Giovannelli, Lisa ^a   Pepeu, Giancarlo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; EXCITOTOXIN; LIPOPOLYSACCHARIDE;

ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; BRAIN TOXICITY; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; DISEASE MODEL; GLIA CELL; INFLAMMATION; NEUROTOXICITY; NONHUMAN; OLIVARY NUCLEUS; PATHOGENESIS; PRIORITY JOURNAL;

AMYLOID BETA-PROTEIN; ANIMALS; BEHAVIOR, ANIMAL; EXCITATORY AMINO ACIDS; LIPOPOLYSACCHARIDES; MALE; MICROINJECTIONS; NEURITIS; NEUROTOXINS; RATS; SUBSTANTIA INNOMINATA;

ANIMALIA;

EID: 0032460878     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(98)00080-X     Document Type: Article

References (69)

1. Abe, E., Casamenti, F., Giovannelli, L., Scali, C. and Pepeu, G., Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo. Brain Res., 1994, 636, 162-164.
2. Arendt, T., Brückner, M. K., Pagliusi, S. and Krell, T., Degeneration of rat cholinergic basal forebrain neurons and reactive changes in nerve growth factor expression after chronic neurotoxic injury - I: degeneration and plastic response of basal forebrain neurons. Neuroscience, 1995, 65, 633-645.
3. Banati, R. B., Gehrmann, J., Schubert, P. and Kreutzberg, G. W., Cytotoxicity of microglia. Glia, 1993, 7, 111-118.
4. Bartolini, L., Casamenti, F. and Pepeu, G., Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol. Biochem. Behav., 1996, 53, 277-283.
5. Bigl, V., Woolf, N. J. and Butcher, L. L., Cholinergic projections from the basal forebrain to frontal, temporal, occipital and cingulates cortices: a combined fluorescent and acetylcholinesterase analysis. Brain Res. Bull., 1982, 8, 727-750.
6. Breitner, J. C. S., Gau, B. A., Welsh, K. A., Plassman, B. L., McDonald, W. M., Helms, M. J. and Antony, J. C., Inverse association of antiinflammatory treatments with Alzheimer's disease: initial results of a co-twin control study. Neurology, 1994, 44, 227-232.
7. Breitner, J. C. S., Welsh, K. A., Helms, M. J., Gaskell, P. C., Gau, B. A., Roses, A. D., Pericak-Vance, M. A. and Saunders, A. M., Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol. Aging, 1995, 16, 523-530.
8. Brugg, B., Dubreuil, Y. L., Huber, G., Wollman, E. E., Delhaye-Bouchaud, N. and Mariani, J., Inflammatory processes induce β-amyloid precursor protein changes in mouse brain. Proc. Natl. Acad. Sci. U.S.A., 1995, 92, 3032-3035.
9. Casamenti, F., Di Patre, P. L., Bartolini, L. and Pepeu, G., Unilateral and bilateral nucleus basalis lesions: differences in neurochemical and behavioural recovery. Neuroscience, 1988, 24, 209-215.
10. Casamenti, F., Di Patre, P. L., Milan, F., Petrelli, L. and Pepeu, G., Effects of nerve growth factor and GM1 ganglioside on the number and size of cholinergic neurons in rats with unilat-eral lesion of the nucleus basalis. Neurosci. Lett., 1989, 103, 87-91.
11. Casamenti, F., Scali, C., Giovannelli, L., Faussone-Pellegrini, M. S. and Pepeu, G., Effect of nerve growth factor and GM1 ganglioside on the recovery of cholinergic neurons after a lesion of the nucleus basalis in aging rats. J. Neural Transm., 1994, 7, 177-193.
12. Casamenti, F., Scali, C. and Pepeu, G., Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study. Eur. J. Pharmacol., 1991, 194, 11-16.
13. Casamenti, F., Scali, C., Vannucchi, M. G., Bartolini, L. and Pepeu, G., Long-term ethanol consumption by rats: effect on acetylcholine release in vivo, choline acetyltransferase activity, and behavior. Neuroscience, 1993, 56, 465-471.
14. Davies, P. and Maloney, A. J. R., Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet, 1976, 2, 1403-1405.
15. Di Patre, P. L., Casamenti, F., Cenni, A. and Pepeu, G., Interaction between nerve growth factor and GM1 monosialoganglioside in preventing cortical choline acetyltransferase and high affinity choline uptake decrease after lesion of the nucleus basalis. Brain Res, 1989, 480, 219-224.
16. Dunnett, S. B., Everitt, B. J. and Robbins, T. W., The basal forebrain cholinergic system: interpreting the functional consequences of excitotoxic lesions. TINS, 1991, 14, 494-501.
17. Dunnett, S. B., Whishaw, I. Q., Jones, G. H. and Bunch, S. T., Behavioural, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neuroscience, 1987, 20, 653-669.
18. Eddleston, M. and Mucke, L., Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience, 1993, 54, 15-36.
19. Emre, M., Geula, C., Ransil, B. J. and Mesulam, M. M., The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected b-amyloid in the rat brain. Neurobiol. Aging, 1992, 13, 553-559.
20. Fisher, A. and Hanin, I., Potential animal models for senile dementia of Alzheimer's type with emphasis on AF64A-induced cholinotoxicity. Ann. Rev. Pharmacol. Toxicol., 1986, 26, 161-181.
21. Fonnum, F., A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem., 1975, 24, 407-409.
22. Frautschy, S. A., Baird, A. and Cole, G. M., Effects of injected Alzheimer b-amyloid cores in rat brain. Proc. Natl. Acad. Sci. U.S.A., 1991, 88, 8362-8366.
23. Games, D., Adams, D., Alessandrini, R., Barbour, R. and Berthelette, P., Alzheimer-type neuripathology in transgenic mice overexpressing V717F β-amyloid protein. Nature, 1995, 373, 523-527.
24. 23a. Giovannelli, L., Casamenti, F. and Pepeu, G., c-Fos expression in the rat nucleus basalis upon excitotoxic lesion with quisqualic acid : a study in adult and aged animals. J. Neural Transm. (in press).
25. Giovannelli, L., Casamenti, F., Scali, C., Bartolini, L. and Pepeu G., Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis. Neuroscience, 1995, 66, 781-792.
26. Giovannelli, L., Scali, C., Faussone-Pellegrini, M.S., Pepeu, G. and Casamenti, F., Long-term changes in the aggregation state and toxic effects of β-amyloid injected into the rat brain. Neuroscience, 1998, 87, 349-357.
27. Griffin, W. S. T., Stanley, L. C., Ling, C., White, C. L., MacLeod, V., Perrot, L. J., White, C. and Araoz, C., Brain interleukin-1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A., 1989, 86, 7611-7615.
28. Griffin, W. S. T., Yeralan, O., Boop, F., Rovnaghi, C. R., Sheng, J. G., Mrak, R. E. and Van Eldik, L. C., Overexpression of the neurotrophic cytokine S100β in human temporal lobe epilepsy. J. Neurochem., 1995, 65, 228-233.
29. Hauss-Wegrzyniak, B., Dobrzanski, P., Stoehr, J. D. and Wenk, G. L., Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease. Brain Res, 1998, 780, 294-303.
30. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. and Cole, G., Correlative memory deficits, Aβ- elevation, and amyloid plaques in transgenic mice. Science, 1996, 274, 99-106.
31. Kang, J., Lemaire, H. G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzesckik, K. H., Multhaup, G., Beyreuther, K. and Muller-Hill, B., The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature, 1987, 325, 733-736.
32. Klegeris, A., Walker, D. G. and McGeer, P. L., Activation of macrophages by Alzheimer β-amyloid peptide. Biochem. Biophys. Res. Commun., 1994, 199, 984-991.
33. Kowall, N. W., McKee, A. C., Yankner, B. A. and Beal, M. F., In vivo neurotoxicity of beta-amyloid β(1-40) and the β(25-35) fragment. Neurobiol. Aging, 1992, 13, 537-542.
34. Kreutzberg, G. W., Microglia : a sensor for pathological events in the CNS. TINS, 1996, 19, 312-318.
35. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A. and Klein, W. L., Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A., 1998, 95, 6448-6453.
36. Levey, A. I., Wainer, B. H., Rye, D. B., Mufson, E. J. and Mesulam, M.-M., Choline acetyltransferase immunoreactive neurons intrinsic to rodent cortex and distinction from acetylcholinesterase-positive neurons. Neuroscience, 1984, 13, 341-353.
37. Lorenzo, A. and Yankner, B. A., β-amyloid neurotoxicity requires fibril formation and is inhibited by Congo Red. Proc. Natl. Acad. Sci. U.S.A., 1994, 91, 12243-12247.
38. Masliah, E., Sisk, A., Mallory, M., Mucke, L., Schenk, D. and Games, D., Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci., 1996, 16, 5796-5811.
39. Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L. and Beyreuther, K., Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc. Natl. Acad. Sci. U.S.A., 1985, 82, 4245-4249.
40. McGeer, P. L. and McGeer, E. G., The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev., 1995, 21, 195-218.
41. Mesulam, M.-M., Mufson, E. J., Levey, A. I. and Wainer, B. H., Cholinergic innervation of cortex by the basal forebrain : cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J. Comp. Neurol., 1983, 214, 170-197.
42. Mesulam, M. M., Mufson, E. J., Vainer, B. H. and Levey, A. I., Central cholinergic pathways in the rat: an overview based on an alternative numenclature (Ch1-Ch6). Neuroscience, 1983, 10(4), 1185-1201.
43. Meynert, T., A Manual of Hystology. Wood, New York, 1872.
44. Moran, P. M., Higgins, L. S., Cordell, B. and Moser, P. C., Age-related learning deficits in transgenic mice expressing the 751-aminoacid isoform of human β-amyloid precursor protein. Proc. Natl. Acad. Sci. U.S.A., 1995, 92, 5341-5345.
45. Muir, J. L., Everitt, B. J. and Robbins, T. W., AMPA-induced excitotoxic lesions of the basal forebrain: a significant role for the cortical cholinergic system in attentional function. J. Neurosci., 1994, 14, 2313-2326.
46. Murray, C. and Fibiger, H. C., Pilocarpine and physostigmine attenuate spatial memory impairments produced by lesions of the nucleus basalis magnocellularis. Behav. Neurosci., 1986, 100, 23-32.
47. Page, K. J., Everitt, B. J., Robbins, T. W., Marston, H. M. and Wilkinson, L. S., Dissociable effects on spatial maze and passive avoidance acquisition and retention following AMPA and ibotenic acid-induced excitotoxic lesions of the basal forebrain in rats : differential dependence on cholinergic neuronal loss. Neuroscience, 1991, 43, 457-472.
48. Pepeu, G. and Casamenti, F., Lesioning the nucleus basalis. In Lesions and Transplantation : Methods in Neurosciences, Vol. 7, ed. P. M. Conn. Academic Press, San Diego, 1991, pp. 139-150.
49. 47a. Pepeu, G., Casamenti, F., Scali, C., Giovannelli, L., Hauss-Wegrzyniak, B., Baker, L. M. and Wenk, G. L., Inflammatory and neurotransmitter response to lipopolysaccharide (LPS), and interleukin-1β (IL-1β) intracerebral injections. Abstract to Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy, 15-18 April, 1998, p. 83.
50. Pike, C. J., Burdick, D., Walencewicz, A. J., Glabe, C. G. and Cotman, C. W., Neurodegeneration induced by β-amyloid peptides in vitro : the role of peptide assembly state. J. Neurosci., 1993, 13, 1676-1687.
51. Pike, C. J., Walenecwicz, A. J., Glabe, C. G. and Cotman, C. W., In vitro aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res, 1990, 563, 311-314.
52. Quan, N., Sundar, S. K. and Weiss, J., Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J. Neuroimmunol., 1994, 49, 125-134.
53. Ridley, R. M., Aitken, D. M. and Baker, H. F., Learning about rules but not about reward is impaired following lesions of the cholinergic projection to the hippocampus. Brain Res. Bull., 1989, 502, 306-318.
54. Robbins, T. W., Everitt, B. J., Marston, H. M., Wilkinson, J., Jones, G. H. and Page, K. J., Comparative effects of ibotenic acid- and quisqualic acid-induced lesions of the substantia innominata on attentional function in the rat : further implications for the role of the cholinergic neurons of the nucleus basalis in cognitive processes. Behav. Brain Res., 1989, 35, 221-240.
55. Rogers, J., Cooper, N. R., Webster, S., Schulz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., Ward, P. and Liebeburg, I., Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A., 1992, 89, 10016-10020.
56. Schäfer, M. K.-H., Eiden, L. E. and Weihe, E., Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system. Neuroscience, 1998, 84, 331-359.
57. Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., Larson, E., Levy-Lahad, E., Viitanen, M., Peskind, E., Poorkaj, P., Schellenberg, G., Tanzi, R., Wasco, W., Lannfelt, L., Selkoe, D. and Younkin, S., Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat. Med., 1996, 2, 864-870.
58. Schmechel, D., Saunders, A. M., Strittmatter, W. J., Crain, B. J., Hulette, C. M., Joo, S. H., Pericak-Vance, M. A., Goldgaber, D. and Roses, A. D., Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein e genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A., 1993, 90, 9649-9653.
59. Selkoe, D. J., Normal and abnormal biology of the β-amyloid precursor protein. Ann. Rev. Neurosci., 1994, 17, 489-517.
60. Smith, G., Animal models of Alzheimer's disease : experimental cholinergic denervation. Brain Res. Rev., 1988, 13, 103-118.
61. Stanley, L. C., Mrak, R. E., Woody, R. C., Perrot, L. J., Zhang, S.-X., Marshak, D. R., Nelson, S. J. and Griffin, W. S. T., Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer's disease. J. Neuropathol. Exp. Neurol., 1994, 53, 231-238.
62. Stewart, W. F., Kawas, C., Corrada, M. and Metter, E. J., Risk of Alzheimer's disease and duration of NSAID use. Neurology, 1997, 48, 628-632.
63. Suzuki, N., Cheung, T. T., Cai, X. D., Odaka, A., Otvos, L. jr, Eckman, C., Golde, T. E. and Younkin, S. G., An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP 717) mutants. Science, 1994, 264, 1336-13440.
64. Thery, C., Chamak, B. and Mallat, M., Free radical killing of neurons. Eur. J. Neurosci., 1991, 3, 1155-1164.
65. Torres, E. M., Perry, T. A., Blokland, A., Wilkinson, L. S., Wiley, R. G., Lappi, D. A. and Dunnett, S. B., Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience, 1994, 63, 95-122.
66. Waite, J. J., Chen, A. D., Wardlow, M. L. and Thai, L. J., Behavioral and biochemical consequences of combined lesions of the medial septum/diagonal band and nucleus basalis in the rat when ibotenic acid, quisqualic acid, and AMPA are used. Exp. Neurol., 1994, 130, 214-229.
67. Wallace, M. N., Geddes, J. G., Farquhar, D. A. and Masson, M. R., Nitric oxide synthase in reactive astrocytes adjacent to β-Amyloid plaques. Exp. Neurol., 1997, 144, 266-272.
68. Yankner, B. A., Duffy, L. K. and Kirschner, D. A., Neurotrophic and neurotoxic effects of amyloid β-protein: reversal by tachykinin neuropeptides. Science, 1990, 250, 279-282.
69. Zupan, G., Casamenti, F., Scali, C. and Pepeu, G., Lesions of the nucleus basalis magnocellularis in immature rats: short- and long-term biochemical and behavioral changes. Pharmacol. Biochem. Behav., 1993, 45, 19-25.